View Single Post
Old 02-13-2012, 01:39 PM   #10
fullofbeans
Senior Member
 
Join Date: Jan 2007
Location: UK
Posts: 617
Re: any tumor tests to predict which chemos work better?

response from rationa therapeutics:

Thank you for your interest in the work of Dr. Robert Nagourney and Rational Therapeutics.

IF chemotherapy is being considered, and IF we can easily obtain a 1-2 cm piece of viable tumor (solid tumor, lymph node, cytologically positive pleural or ascites fluid), received in our laboratory within 24-48 hours of collection, our goal would be to expose the living tumor cells to a wide panel of standard agents and novel combinations. Under this approach, “functional profiling” measures the response of tumor cells when exposed to chemotherapies in the laboratory. By identifying which agents induce the tumor to shut down and die and also which ones do not, we can aid your oncologist in choosing the most effective chemotherapy regimen based on your unique tumor makeup; additionally sparing unnecessary toxicity associated with ineffective treatments.


Functional profiling is not intended to be a scale model of chemotherapy in the patient, anymore than the barometric pressure is a scale model of the weather. But it’s always more likely to rain when the barometer is falling than when it is rising, and chemotherapy is more likely to work in the patient when it kills the patient’s cancer cells in the laboratory. Data reveals that our personalized "functional profile" increases response rates 2-3 times that of standard protocols.

We would be happy to discuss specifics or answer any questions. International specimens are do-able although complicated and problematic due to the timeframe in receiving viable tumor tissue. We have worked with World Courier to handle international shipments. They are expert and Customs, etc. but are not inexpensive (I would estimate $1000-$2000 just for transportation). If our program makes sense, please do not hesitate to contact us directly.



Rational Therapeutics
Physician/Patient Relations
__________________

35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies

Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..

superior vena cava blocked: stent but face remains puffy

April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.

Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.



'Under no circumstances should you lose hope..' Dalai Lama
fullofbeans is offline   Reply With Quote